Efalizumab binding to the LFA-1 αL I domain blocks ICAM-1 binding via steric hindrance
By Sheng Li, B. Peng, Meilan Zhang, Dai-Zun Zhang, S. Hou, Ya-jun Guo, Jianping Ding. 2009
60 citations recorded by the source corpus.
Subfields: Immunology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Radiology, Nuclear Medicine and Imaging
- Brian G. Pierce
- Alexandre M. J. J. Bonvin
- Juan Fernández-Recio
- Thom Vreven
- Iain H. Moal
- Paul A. Bates
- Mieczyslaw Torchala
- Zhiping Weng
Citations in the corpus
- Towards automated crystallographic structure refinement with phenix.refine (2012, neutral): “…structures with PDB entries 1jl4 (Wang et al., 2001), 2gsz (Satyshur et al., 2007), 1yi5 (Bourne et al., 2005), 2wjx (Clayton et al., 2009), 3eob (Li et al., 2009), 1av1 (Brouillette & Anantharamaiah, 1995), 3bbw (Qiu et al., 2008) and 2i07 (Janssen et al., 2006) were selected because their…”
- Updates to the integrated protein-protein interaction benchmarks: Docking benchmark version 5 and affinity benchmark version 2 (2015, methodology): “ZAPP predicts protein-protein binding free energies using a linear combination of nine energy terms and a constant [26].”